497 related articles for article (PubMed ID: 32561389)
1. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
Valent P; Akin C; Bonadonna P; Brockow K; Niedoszytko M; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Reiter A; Castells M; Sperr WR; Kluin-Nelemans HC; Hermine O; Gotlib J; Zanotti R; Broesby-Olsen S; Horny HP; Triggiani M; Siebenhaar F; Orfao A; Metcalfe DD; Arock M; Hartmann K
J Allergy Clin Immunol; 2020 Aug; 146(2):300-306. PubMed ID: 32561389
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?
Theoharides TC; Conti P
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1633-1636. PubMed ID: 33023287
[TBL] [Abstract][Full Text] [Related]
3. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
6. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
7. The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond.
Russell N; Jennings S; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1157-1165.e6. PubMed ID: 30098409
[TBL] [Abstract][Full Text] [Related]
8. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
9. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
Abootalebi S; Aertker BM; Andalibi MS; Asdaghi N; Aykac O; Azarpazhooh MR; Bahit MC; Barlinn K; Basri H; Shahripour RB; Bersano A; Biller J; Borhani-Haghighi A; Brown RD; Campbell BC; Cruz-Flores S; De Silva DA; Di Napoli M; Divani AA; Edgell RC; Fifi JT; Ghoreishi A; Hirano T; Hong KS; Hsu CY; Huang JF; Inoue M; Jagolino AL; Kapral M; Kee HF; Keser Z; Khatri R; Koga M; Krupinski J; Liebeskind DS; Liu L; Ma H; Maud A; McCullough LD; Meyer DM; Mifsud V; Morovatdar N; Nilanont Y; Oxley TJ; Özdemir AÖ; Pandian J; Pantoni L; Papamitsakis NIH; Parry-Jones A; Phan T; Rodriguez G; Romano JG; Sabaa-Ayoun Z; Saber H; Sasannezhad P; Saver JL; Scharf E; Shuaib A; Silver B; Singhal S; Smith CJ; Stranges S; Sylaja PN; Torbey M; Toyoda K; Tsivgoulis G; Wasay M; Yassi N; Yoshimoto T; Zamani B; Zand R
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104938. PubMed ID: 32807412
[TBL] [Abstract][Full Text] [Related]
10. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
11. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
13. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
[TBL] [Abstract][Full Text] [Related]
14. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A
Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
Lichtenstein GR; Rubin DT
Am J Gastroenterol; 2020 Oct; 115(10):1566-1569. PubMed ID: 32833732
[No Abstract] [Full Text] [Related]
16. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.
Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
Huang G; Kovalic AJ; Graber CJ
Emerg Infect Dis; 2020 Aug; 26(8):1839-1841. PubMed ID: 32384045
[TBL] [Abstract][Full Text] [Related]
18. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
Ghosh N; Tirpack A; Chan KK; Bass AR
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic methods in the COVID-19 pandemic, today and in the future.
Wu SY; Yau HS; Yu MY; Tsang HF; Chan LWC; Cho WCS; Shing Yu AC; Yuen Yim AK; Li MJW; Wong YKE; Pei XM; Cesar Wong SC
Expert Rev Mol Diagn; 2020 Sep; 20(9):985-993. PubMed ID: 32845192
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.
Raza H; Wahid B; Rubi G; Gulzar A
Infect Genet Evol; 2020 Oct; 84():104374. PubMed ID: 32450246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
